ALICIA WETTRICK: Open Payments
NPI 1285649913 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 31 payments from 10 companies in 2025. Trend: 2023 $27,723 · 2024 $11,639 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 10 | $234 |
| Hologic Sales and Service, LLC | 3 | $178 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $113 |
| Exeltis, USA Inc. | 3 | $60 |
| Biogen, Inc. | 2 | $44 |
| MILLICENT US INC | 2 | $35 |
| Organon LLC | 1 | $30 |
| CooperSurgical, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: Veozah, NOVASURE, SLYND, ZURZUVAE, FEMLYV, NEXPLANON, Paragard T 380A, Dexcom G6 Transmitter.
Industry payments across IN — which companies pay providers there.
